Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases

► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRS-1 and IRS-2 form high-molecular-mass complexes with other proteins. ► Different complexes are formed depending on IRS-isoform, cell-type or stimulus. ► The complexes can modulate availability of IRSs to receptor tyro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2011-01, Vol.404 (3), p.767-773
Hauptverfasser: Fukushima, Toshiaki, Arai, Toshiya, Ariga-Nedachi, Miyako, Okajima, Hiroshi, Ooi, Yuko, Iijima, Yumi, Sone, Meri, Cho, Yoshitake, Ando, Yasutoshi, Kasahara, Kohei, Ozoe, Atsufumi, Yoshihara, Hidehito, Chida, Kazuhiro, Okada, Shigeru, Kopchick, John J., Asano, Tomoichiro, Hakuno, Fumihiko, Takahashi, Shin-Ichiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 773
container_issue 3
container_start_page 767
container_title Biochemical and biophysical research communications
container_volume 404
creator Fukushima, Toshiaki
Arai, Toshiya
Ariga-Nedachi, Miyako
Okajima, Hiroshi
Ooi, Yuko
Iijima, Yumi
Sone, Meri
Cho, Yoshitake
Ando, Yasutoshi
Kasahara, Kohei
Ozoe, Atsufumi
Yoshihara, Hidehito
Chida, Kazuhiro
Okada, Shigeru
Kopchick, John J.
Asano, Tomoichiro
Hakuno, Fumihiko
Takahashi, Shin-Ichiro
description ► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRS-1 and IRS-2 form high-molecular-mass complexes with other proteins. ► Different complexes are formed depending on IRS-isoform, cell-type or stimulus. ► The complexes can modulate availability of IRSs to receptor tyrosine kinases. Insulin receptor substrates (IRSs) are phosphorylated by activated insulin/insulin-like growth factor (IGF)-I receptor tyrosine kinases. Phosphotyrosyl IRSs are recognized by signaling molecules possessing src homology region 2 (SH2) domains, which mediate various insulin/IGF bioactivities. However, we have shown that IRSs are also associated with other proteins by a phosphotyrosine-independent mechanism. Here, we demonstrated that IRSs form high-molecular-mass complexes (we named these complexes IRSomes) with various proteins and we elucidated their possible roles. Blue native-polyacrylamide gel electrophoresis of cell lysates revealed IRSome formation. Some proteins associated with IRSs in IRS-isoform-, cell-type-, or stimulus-specific manners. Results of the in vitro tyrosine phosphorylation assay indicated that tyrosine phosphorylation of IRS-1 by insulin receptor was decreased when IRS-1 was contained in IRSomes prepared from 3T3-L1 adipocytes treated with TNF-α. Also, tyrosine phosphorylation of IRS-2 by IGF-I receptor was increased when IRS-2 was contained in IRSomes prepared from FRTL-5 thyrocytes treated with dibutyryl cAMP. These results demonstrated that cytokine/hormone-induced formation of IRSomes modulates availability of IRSs to receptor tyrosine kinases.
doi_str_mv 10.1016/j.bbrc.2010.12.045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_847279533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X10022837</els_id><sourcerecordid>847279533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-971ddd55e06a0b27ffb004140589ccdf9dede84dc9ad74b538e2dc0bca6087b23</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhlcIRNPCH-AAvnHadOz9tMQFVVAiVeIAlbhZ_phNnHrXwfYW8nP4pzjaADdOI3ueed_RvEXxisKaAm2v92ulgl4zOH2wNdTNk2JFgUPJKNRPixUAtCXj9NtFcRnjHoDSuuXPiwtGadtXHFbFr80UZ2cnElDjIflA4qxiCjJhJIMPI9nZ7a4cvUM9OxnKUcZItB8PDn9mJO1kIqM3uZcwv9AGIh-ldVJZZ9ORJE_sYnF9rqWzD0i2wf9IOzJInU3LzT__dAw-2gnJg51kxPiieDZIF_HluV4V9x8_fL35VN59vt3cvL8rdc2qVPKOGmOaBqGVoFg3DAqgpjU0PdfaDNygwb42mkvT1aqpemRGg9Kyhb5TrLoq3i66h-C_zxiTGG3U6Jyc0M9R9HXHOt5UVSbZQuq8aQw4iEOwowxHQUGckhF7cUpGnJIRlImcTB56fZaf1Yjm78ifKDLwZgEG6YXcBhvF_Zes0MApxo7TTLxbCMxneLQYRNQWJ43G5uslYbz93wa_AddyroM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>847279533</pqid></control><display><type>article</type><title>Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fukushima, Toshiaki ; Arai, Toshiya ; Ariga-Nedachi, Miyako ; Okajima, Hiroshi ; Ooi, Yuko ; Iijima, Yumi ; Sone, Meri ; Cho, Yoshitake ; Ando, Yasutoshi ; Kasahara, Kohei ; Ozoe, Atsufumi ; Yoshihara, Hidehito ; Chida, Kazuhiro ; Okada, Shigeru ; Kopchick, John J. ; Asano, Tomoichiro ; Hakuno, Fumihiko ; Takahashi, Shin-Ichiro</creator><creatorcontrib>Fukushima, Toshiaki ; Arai, Toshiya ; Ariga-Nedachi, Miyako ; Okajima, Hiroshi ; Ooi, Yuko ; Iijima, Yumi ; Sone, Meri ; Cho, Yoshitake ; Ando, Yasutoshi ; Kasahara, Kohei ; Ozoe, Atsufumi ; Yoshihara, Hidehito ; Chida, Kazuhiro ; Okada, Shigeru ; Kopchick, John J. ; Asano, Tomoichiro ; Hakuno, Fumihiko ; Takahashi, Shin-Ichiro</creatorcontrib><description>► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRS-1 and IRS-2 form high-molecular-mass complexes with other proteins. ► Different complexes are formed depending on IRS-isoform, cell-type or stimulus. ► The complexes can modulate availability of IRSs to receptor tyrosine kinases. Insulin receptor substrates (IRSs) are phosphorylated by activated insulin/insulin-like growth factor (IGF)-I receptor tyrosine kinases. Phosphotyrosyl IRSs are recognized by signaling molecules possessing src homology region 2 (SH2) domains, which mediate various insulin/IGF bioactivities. However, we have shown that IRSs are also associated with other proteins by a phosphotyrosine-independent mechanism. Here, we demonstrated that IRSs form high-molecular-mass complexes (we named these complexes IRSomes) with various proteins and we elucidated their possible roles. Blue native-polyacrylamide gel electrophoresis of cell lysates revealed IRSome formation. Some proteins associated with IRSs in IRS-isoform-, cell-type-, or stimulus-specific manners. Results of the in vitro tyrosine phosphorylation assay indicated that tyrosine phosphorylation of IRS-1 by insulin receptor was decreased when IRS-1 was contained in IRSomes prepared from 3T3-L1 adipocytes treated with TNF-α. Also, tyrosine phosphorylation of IRS-2 by IGF-I receptor was increased when IRS-2 was contained in IRSomes prepared from FRTL-5 thyrocytes treated with dibutyryl cAMP. These results demonstrated that cytokine/hormone-induced formation of IRSomes modulates availability of IRSs to receptor tyrosine kinases.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2010.12.045</identifier><identifier>PMID: 21168390</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>3T3-L1 Cells ; adipocytes ; Adipocytes - metabolism ; Animals ; bioactive properties ; Bucladesine - metabolism ; cAMP ; gel electrophoresis ; HEK293 Cells ; Humans ; Insulin ; Insulin - metabolism ; Insulin receptor substrate (IRS) ; Insulin Receptor Substrate Proteins - metabolism ; insulin receptors ; Insulin-like growth factor (IGF) ; insulin-like growth factor I receptor ; Mice ; Multiprotein Complexes - metabolism ; Phosphorylation ; protein phosphorylation ; Receptor, IGF Type 1 - metabolism ; signal transducing adaptor proteins ; Thyroid Gland - cytology ; Thyroid Gland - metabolism ; Tumor necrosis factor (TNF)-α ; tumor necrosis factor-alpha ; Tumor Necrosis Factor-alpha - pharmacology ; tyrosine ; Tyrosine - metabolism ; Tyrosine phosphorylation</subject><ispartof>Biochemical and biophysical research communications, 2011-01, Vol.404 (3), p.767-773</ispartof><rights>2010 Elsevier Inc.</rights><rights>Copyright © 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-971ddd55e06a0b27ffb004140589ccdf9dede84dc9ad74b538e2dc0bca6087b23</citedby><cites>FETCH-LOGICAL-c423t-971ddd55e06a0b27ffb004140589ccdf9dede84dc9ad74b538e2dc0bca6087b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbrc.2010.12.045$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21168390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fukushima, Toshiaki</creatorcontrib><creatorcontrib>Arai, Toshiya</creatorcontrib><creatorcontrib>Ariga-Nedachi, Miyako</creatorcontrib><creatorcontrib>Okajima, Hiroshi</creatorcontrib><creatorcontrib>Ooi, Yuko</creatorcontrib><creatorcontrib>Iijima, Yumi</creatorcontrib><creatorcontrib>Sone, Meri</creatorcontrib><creatorcontrib>Cho, Yoshitake</creatorcontrib><creatorcontrib>Ando, Yasutoshi</creatorcontrib><creatorcontrib>Kasahara, Kohei</creatorcontrib><creatorcontrib>Ozoe, Atsufumi</creatorcontrib><creatorcontrib>Yoshihara, Hidehito</creatorcontrib><creatorcontrib>Chida, Kazuhiro</creatorcontrib><creatorcontrib>Okada, Shigeru</creatorcontrib><creatorcontrib>Kopchick, John J.</creatorcontrib><creatorcontrib>Asano, Tomoichiro</creatorcontrib><creatorcontrib>Hakuno, Fumihiko</creatorcontrib><creatorcontrib>Takahashi, Shin-Ichiro</creatorcontrib><title>Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRS-1 and IRS-2 form high-molecular-mass complexes with other proteins. ► Different complexes are formed depending on IRS-isoform, cell-type or stimulus. ► The complexes can modulate availability of IRSs to receptor tyrosine kinases. Insulin receptor substrates (IRSs) are phosphorylated by activated insulin/insulin-like growth factor (IGF)-I receptor tyrosine kinases. Phosphotyrosyl IRSs are recognized by signaling molecules possessing src homology region 2 (SH2) domains, which mediate various insulin/IGF bioactivities. However, we have shown that IRSs are also associated with other proteins by a phosphotyrosine-independent mechanism. Here, we demonstrated that IRSs form high-molecular-mass complexes (we named these complexes IRSomes) with various proteins and we elucidated their possible roles. Blue native-polyacrylamide gel electrophoresis of cell lysates revealed IRSome formation. Some proteins associated with IRSs in IRS-isoform-, cell-type-, or stimulus-specific manners. Results of the in vitro tyrosine phosphorylation assay indicated that tyrosine phosphorylation of IRS-1 by insulin receptor was decreased when IRS-1 was contained in IRSomes prepared from 3T3-L1 adipocytes treated with TNF-α. Also, tyrosine phosphorylation of IRS-2 by IGF-I receptor was increased when IRS-2 was contained in IRSomes prepared from FRTL-5 thyrocytes treated with dibutyryl cAMP. These results demonstrated that cytokine/hormone-induced formation of IRSomes modulates availability of IRSs to receptor tyrosine kinases.</description><subject>3T3-L1 Cells</subject><subject>adipocytes</subject><subject>Adipocytes - metabolism</subject><subject>Animals</subject><subject>bioactive properties</subject><subject>Bucladesine - metabolism</subject><subject>cAMP</subject><subject>gel electrophoresis</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin - metabolism</subject><subject>Insulin receptor substrate (IRS)</subject><subject>Insulin Receptor Substrate Proteins - metabolism</subject><subject>insulin receptors</subject><subject>Insulin-like growth factor (IGF)</subject><subject>insulin-like growth factor I receptor</subject><subject>Mice</subject><subject>Multiprotein Complexes - metabolism</subject><subject>Phosphorylation</subject><subject>protein phosphorylation</subject><subject>Receptor, IGF Type 1 - metabolism</subject><subject>signal transducing adaptor proteins</subject><subject>Thyroid Gland - cytology</subject><subject>Thyroid Gland - metabolism</subject><subject>Tumor necrosis factor (TNF)-α</subject><subject>tumor necrosis factor-alpha</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>tyrosine</subject><subject>Tyrosine - metabolism</subject><subject>Tyrosine phosphorylation</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1vEzEQhlcIRNPCH-AAvnHadOz9tMQFVVAiVeIAlbhZ_phNnHrXwfYW8nP4pzjaADdOI3ueed_RvEXxisKaAm2v92ulgl4zOH2wNdTNk2JFgUPJKNRPixUAtCXj9NtFcRnjHoDSuuXPiwtGadtXHFbFr80UZ2cnElDjIflA4qxiCjJhJIMPI9nZ7a4cvUM9OxnKUcZItB8PDn9mJO1kIqM3uZcwv9AGIh-ldVJZZ9ORJE_sYnF9rqWzD0i2wf9IOzJInU3LzT__dAw-2gnJg51kxPiieDZIF_HluV4V9x8_fL35VN59vt3cvL8rdc2qVPKOGmOaBqGVoFg3DAqgpjU0PdfaDNygwb42mkvT1aqpemRGg9Kyhb5TrLoq3i66h-C_zxiTGG3U6Jyc0M9R9HXHOt5UVSbZQuq8aQw4iEOwowxHQUGckhF7cUpGnJIRlImcTB56fZaf1Yjm78ifKDLwZgEG6YXcBhvF_Zes0MApxo7TTLxbCMxneLQYRNQWJ43G5uslYbz93wa_AddyroM</recordid><startdate>20110121</startdate><enddate>20110121</enddate><creator>Fukushima, Toshiaki</creator><creator>Arai, Toshiya</creator><creator>Ariga-Nedachi, Miyako</creator><creator>Okajima, Hiroshi</creator><creator>Ooi, Yuko</creator><creator>Iijima, Yumi</creator><creator>Sone, Meri</creator><creator>Cho, Yoshitake</creator><creator>Ando, Yasutoshi</creator><creator>Kasahara, Kohei</creator><creator>Ozoe, Atsufumi</creator><creator>Yoshihara, Hidehito</creator><creator>Chida, Kazuhiro</creator><creator>Okada, Shigeru</creator><creator>Kopchick, John J.</creator><creator>Asano, Tomoichiro</creator><creator>Hakuno, Fumihiko</creator><creator>Takahashi, Shin-Ichiro</creator><general>Elsevier Inc</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110121</creationdate><title>Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases</title><author>Fukushima, Toshiaki ; Arai, Toshiya ; Ariga-Nedachi, Miyako ; Okajima, Hiroshi ; Ooi, Yuko ; Iijima, Yumi ; Sone, Meri ; Cho, Yoshitake ; Ando, Yasutoshi ; Kasahara, Kohei ; Ozoe, Atsufumi ; Yoshihara, Hidehito ; Chida, Kazuhiro ; Okada, Shigeru ; Kopchick, John J. ; Asano, Tomoichiro ; Hakuno, Fumihiko ; Takahashi, Shin-Ichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-971ddd55e06a0b27ffb004140589ccdf9dede84dc9ad74b538e2dc0bca6087b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>3T3-L1 Cells</topic><topic>adipocytes</topic><topic>Adipocytes - metabolism</topic><topic>Animals</topic><topic>bioactive properties</topic><topic>Bucladesine - metabolism</topic><topic>cAMP</topic><topic>gel electrophoresis</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin - metabolism</topic><topic>Insulin receptor substrate (IRS)</topic><topic>Insulin Receptor Substrate Proteins - metabolism</topic><topic>insulin receptors</topic><topic>Insulin-like growth factor (IGF)</topic><topic>insulin-like growth factor I receptor</topic><topic>Mice</topic><topic>Multiprotein Complexes - metabolism</topic><topic>Phosphorylation</topic><topic>protein phosphorylation</topic><topic>Receptor, IGF Type 1 - metabolism</topic><topic>signal transducing adaptor proteins</topic><topic>Thyroid Gland - cytology</topic><topic>Thyroid Gland - metabolism</topic><topic>Tumor necrosis factor (TNF)-α</topic><topic>tumor necrosis factor-alpha</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>tyrosine</topic><topic>Tyrosine - metabolism</topic><topic>Tyrosine phosphorylation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukushima, Toshiaki</creatorcontrib><creatorcontrib>Arai, Toshiya</creatorcontrib><creatorcontrib>Ariga-Nedachi, Miyako</creatorcontrib><creatorcontrib>Okajima, Hiroshi</creatorcontrib><creatorcontrib>Ooi, Yuko</creatorcontrib><creatorcontrib>Iijima, Yumi</creatorcontrib><creatorcontrib>Sone, Meri</creatorcontrib><creatorcontrib>Cho, Yoshitake</creatorcontrib><creatorcontrib>Ando, Yasutoshi</creatorcontrib><creatorcontrib>Kasahara, Kohei</creatorcontrib><creatorcontrib>Ozoe, Atsufumi</creatorcontrib><creatorcontrib>Yoshihara, Hidehito</creatorcontrib><creatorcontrib>Chida, Kazuhiro</creatorcontrib><creatorcontrib>Okada, Shigeru</creatorcontrib><creatorcontrib>Kopchick, John J.</creatorcontrib><creatorcontrib>Asano, Tomoichiro</creatorcontrib><creatorcontrib>Hakuno, Fumihiko</creatorcontrib><creatorcontrib>Takahashi, Shin-Ichiro</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukushima, Toshiaki</au><au>Arai, Toshiya</au><au>Ariga-Nedachi, Miyako</au><au>Okajima, Hiroshi</au><au>Ooi, Yuko</au><au>Iijima, Yumi</au><au>Sone, Meri</au><au>Cho, Yoshitake</au><au>Ando, Yasutoshi</au><au>Kasahara, Kohei</au><au>Ozoe, Atsufumi</au><au>Yoshihara, Hidehito</au><au>Chida, Kazuhiro</au><au>Okada, Shigeru</au><au>Kopchick, John J.</au><au>Asano, Tomoichiro</au><au>Hakuno, Fumihiko</au><au>Takahashi, Shin-Ichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2011-01-21</date><risdate>2011</risdate><volume>404</volume><issue>3</issue><spage>767</spage><epage>773</epage><pages>767-773</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>► We examine protein complexes containing insulin receptor substrates (IRSs). ► IRS-1 and IRS-2 form high-molecular-mass complexes with other proteins. ► Different complexes are formed depending on IRS-isoform, cell-type or stimulus. ► The complexes can modulate availability of IRSs to receptor tyrosine kinases. Insulin receptor substrates (IRSs) are phosphorylated by activated insulin/insulin-like growth factor (IGF)-I receptor tyrosine kinases. Phosphotyrosyl IRSs are recognized by signaling molecules possessing src homology region 2 (SH2) domains, which mediate various insulin/IGF bioactivities. However, we have shown that IRSs are also associated with other proteins by a phosphotyrosine-independent mechanism. Here, we demonstrated that IRSs form high-molecular-mass complexes (we named these complexes IRSomes) with various proteins and we elucidated their possible roles. Blue native-polyacrylamide gel electrophoresis of cell lysates revealed IRSome formation. Some proteins associated with IRSs in IRS-isoform-, cell-type-, or stimulus-specific manners. Results of the in vitro tyrosine phosphorylation assay indicated that tyrosine phosphorylation of IRS-1 by insulin receptor was decreased when IRS-1 was contained in IRSomes prepared from 3T3-L1 adipocytes treated with TNF-α. Also, tyrosine phosphorylation of IRS-2 by IGF-I receptor was increased when IRS-2 was contained in IRSomes prepared from FRTL-5 thyrocytes treated with dibutyryl cAMP. These results demonstrated that cytokine/hormone-induced formation of IRSomes modulates availability of IRSs to receptor tyrosine kinases.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>21168390</pmid><doi>10.1016/j.bbrc.2010.12.045</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2011-01, Vol.404 (3), p.767-773
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_847279533
source MEDLINE; Elsevier ScienceDirect Journals
subjects 3T3-L1 Cells
adipocytes
Adipocytes - metabolism
Animals
bioactive properties
Bucladesine - metabolism
cAMP
gel electrophoresis
HEK293 Cells
Humans
Insulin
Insulin - metabolism
Insulin receptor substrate (IRS)
Insulin Receptor Substrate Proteins - metabolism
insulin receptors
Insulin-like growth factor (IGF)
insulin-like growth factor I receptor
Mice
Multiprotein Complexes - metabolism
Phosphorylation
protein phosphorylation
Receptor, IGF Type 1 - metabolism
signal transducing adaptor proteins
Thyroid Gland - cytology
Thyroid Gland - metabolism
Tumor necrosis factor (TNF)-α
tumor necrosis factor-alpha
Tumor Necrosis Factor-alpha - pharmacology
tyrosine
Tyrosine - metabolism
Tyrosine phosphorylation
title Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A11%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin%20receptor%20substrates%20form%20high-molecular-mass%20complexes%20that%20modulate%20their%20availability%20to%20insulin/insulin-like%20growth%20factor-I%20receptor%20tyrosine%20kinases&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Fukushima,%20Toshiaki&rft.date=2011-01-21&rft.volume=404&rft.issue=3&rft.spage=767&rft.epage=773&rft.pages=767-773&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2010.12.045&rft_dat=%3Cproquest_cross%3E847279533%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=847279533&rft_id=info:pmid/21168390&rft_els_id=S0006291X10022837&rfr_iscdi=true